Urinary Incontinence Devices

Urinary Incontinence Devices Market Outlook

The global urinary incontinence devices market is projected to reach an estimated USD 3.5 billion by 2035, growing at a CAGR of 4.5% during the forecast period of 2025 to 2035. This growth is primarily driven by the increasing prevalence of urinary incontinence, particularly among the aging population, as well as the rising awareness and acceptance of incontinence products. Additionally, advancements in medical technology and the introduction of innovative product features are propelling market growth. Another contributing factor is the growing healthcare expenditure and the demand for improved patient care solutions, which further supports the expansion of this market. The integration of telemedicine and homecare services has also created new opportunities for manufacturers to reach consumers directly, thereby accelerating market dynamics.

Growth Factor of the Market

The urinary incontinence devices market is experiencing robust growth due to several critical factors, including demographic shifts and evolving consumer preferences. One of the leading factors is the increasing prevalence of urinary incontinence, especially among the elderly population, which is projected to rise significantly in the coming years. With more people seeking effective solutions, there’s a heightened demand for innovative devices designed to enhance comfort and usability. Furthermore, advancements in technology have led to the development of more efficient and user-friendly devices, which appeal to both patients and healthcare providers alike. The increased focus on women's health and wellness has also spurred awareness and acceptance of these products, leading to growth in various segments of the market. Additionally, the expansion of outpatient surgical procedures has made urinary incontinence devices more accessible, thus driving market growth.

Key Highlights of the Market

• The global urinary incontinence devices market is expected to grow at a steady CAGR of 4.5% between 2025 and 2035.
• Rising awareness and acceptance of urinary incontinence products among consumers are contributing to market expansion.
• Technological advancements are enhancing the efficiency and usability of urinary incontinence devices.
• Growing healthcare expenditures and improved access to treatment options are paving the way for market growth.
• The demographic shift towards an aging population is a significant driver for increased product demand.

By Product Type

Electrical Stimulation Devices:

Electrical stimulation devices are designed to help manage urinary incontinence through neuromodulation techniques. These devices work by sending electrical impulses to the nerves that control bladder function, thereby reducing involuntary contractions and enhancing bladder control. This segment is gaining traction due to its non-invasive nature and effectiveness in treating various forms of urinary incontinence, including stress and urge incontinence. The growing preference for minimally invasive treatment options is a significant factor driving the demand for electrical stimulation devices. Furthermore, technological advancements have improved the design and efficacy of these devices, contributing to their growing adoption among both patients and healthcare providers.

Foley Catheters:

Foley catheters are widely utilized in hospitals and healthcare facilities for managing urinary retention and incontinence. These devices are inserted into the bladder to facilitate urine drainage and are essential in various clinical settings. The demand for Foley catheters is driven by the increasing number of surgical procedures and the rising incidence of urinary tract infections, necessitating effective urinary management solutions. The development of advanced materials and designs has improved the comfort and safety of Foley catheters, making them a preferred choice for many healthcare professionals. Additionally, the growing awareness regarding the importance of catheter care and hygiene is further propelling the market for Foley catheters and contributing to their sustained growth.

Absorbent Products:

Absorbent products, including pads and adult diapers, are among the most commonly used urinary incontinence devices. This segment is particularly popular due to its convenience and discretion, making it an attractive option for individuals seeking to manage incontinence in daily life. The increasing awareness about bladder health and the rising number of women experiencing postpartum incontinence are significant factors driving the demand for absorbent products. Additionally, advancements in material technology have led to the production of thinner, more absorbent, and comfortable products, enhancing user experience. The expanding e-commerce market has also facilitated the accessibility of absorbent products, further contributing to their growth in the urinary incontinence market.

Artificial Urinary Sphincters:

Artificial urinary sphincters are innovative devices used to treat severe cases of urinary incontinence, particularly among men who have undergone prostate surgery. These devices mimic the function of the natural urinary sphincter, allowing patients to regain control over their bladder function. The increasing prevalence of prostate-related conditions and subsequent surgeries is driving the demand for artificial urinary sphincters. Moreover, the continuous advancements in surgical techniques and device design have improved the effectiveness and safety profile of these devices, making them a viable option for many patients. Increased training and awareness among urologists regarding the use of artificial urinary sphincters are also contributing to market growth.

Urethral Bulking Agents:

Urethral bulking agents are injectable substances used to treat urinary incontinence by increasing the bulk of the urethra, thus preventing involuntary leakage. This non-invasive approach has gained popularity due to its effectiveness and lower risk of complications compared to surgical options. The growing acceptance of minimally invasive procedures is significantly boosting the demand for urethral bulking agents. Additionally, advancements in materials used for bulking agents have enhanced their safety and longevity, encouraging more patients to consider this treatment option. The rising emphasis on women's health and increased awareness of available treatment options are further fueling the growth of this segment within the urinary incontinence devices market.

By Application

Hospitals:

Hospitals are a major segment for the urinary incontinence devices market, as they frequently encounter patients requiring effective urinary management solutions. The increasing number of surgical procedures performed in hospitals contributes to the growing demand for products like Foley catheters and absorbent products. Hospitals are also adopting advanced technologies for urinary incontinence treatment, including electrical stimulation devices and artificial urinary sphincters. As healthcare standards continue to rise, hospitals are increasingly focusing on improving patient comfort and care, driving the adoption of innovative urinary incontinence devices. The integration of multidisciplinary teams in hospitals is also leading to a better understanding of urinary incontinence management, creating a conducive environment for market growth.

Clinics:

Clinics, particularly urology and gynecology practices, play a vital role in offering urinary incontinence devices to patients seeking treatment outside of hospital settings. The growing trend of outpatient care, coupled with the increased awareness about urinary incontinence, has led to a surge in demand for effective management solutions within clinics. Clinics offer personalized care and tailored treatment plans, making them attractive to patients who prefer a more individualized approach. Additionally, the availability of a range of devices—including electrical stimulation devices and urethral bulking agents—positions clinics as key players in the urinary incontinence devices market. The focus on patient education and support in clinics also encourages patients to seek timely treatment, further driving the growth of this segment.

Homecare Settings:

Homecare settings are increasingly emerging as significant venues for the use of urinary incontinence devices, driven by the growing aging population and the preference for home-based care. Patients are seeking comfortable and discreet solutions to manage their incontinence in the privacy of their own homes, resulting in heightened demand for absorbent products and other devices. Furthermore, advancements in telehealth and remote monitoring technologies have made it easier for healthcare providers to offer support and care to patients at home. This shift towards homecare is encouraging manufacturers to develop more user-friendly and accessible devices tailored for home use. The trend of aging in place is also propelling the growth of the homecare segment within the urinary incontinence devices market.

Nursing Homes:

Nursing homes represent a substantial segment of the urinary incontinence devices market, as they cater to a high number of elderly individuals who often experience incontinence issues. The need for effective management solutions in nursing homes is critical to maintaining the quality of life for residents. Nursing homes are increasingly adopting a wide variety of urinary incontinence devices, from absorbent products to more sophisticated solutions like electrical stimulation devices. The focus on creating a comfortable and dignified living environment for residents is driving the demand for high-quality incontinence products. Furthermore, the emphasis on staff training and education regarding the use of these devices enhances the overall care provided in nursing homes, further supporting market growth.

By Distribution Channel

Online Stores:

Online stores are rapidly becoming a dominant distribution channel for urinary incontinence devices, driven by the increasing preference for e-commerce among consumers. Online platforms provide convenience, privacy, and a wider selection of products, making it easier for individuals to purchase incontinence devices from the comfort of their homes. The rise of direct-to-consumer brands has also contributed to the growth of online sales, allowing manufacturers to establish a direct relationship with customers. Additionally, online stores often offer competitive pricing and special promotions, attracting more consumers to purchase urinary incontinence products through this channel. The COVID-19 pandemic has further accelerated the shift towards online shopping, underscoring the importance of this distribution channel in the urinary incontinence devices market.

Medical Stores:

Medical stores play an integral role in the distribution of urinary incontinence devices, serving as crucial points of access for patients seeking reliable and tested products. These stores are often staffed by trained professionals who can provide guidance and recommendations to consumers, enhancing the overall shopping experience. The convenience of purchasing incontinence products in local medical stores is a significant draw for patients, especially those who may prefer in-person consultations. Additionally, medical stores are likely to carry a range of products, including absorbent items, Foley catheters, and more, catering to diverse patient needs. The growing awareness about urinary incontinence and increased foot traffic in medical stores are contributing factors to the growth of this distribution channel.

Retail Pharmacies:

Retail pharmacies are essential distribution channels within the urinary incontinence devices market, providing consumers with easy access to a variety of products. Many consumers prefer purchasing urinary incontinence devices from their local pharmacies due to the convenience and immediacy of availability. Retail pharmacies often stock a range of absorbent products and over-the-counter solutions, making it easier for individuals to find suitable options for their needs. Furthermore, pharmacists play a crucial role in educating customers about urinary incontinence and possible treatment options, fostering trust and encouraging product sales. The growing emphasis on patient care and wellness within retail pharmacies is enhancing the product offerings and services available to consumers, thus positively influencing market growth.

Hospitals:

Hospitals serve as a critical distribution channel for urinary incontinence devices, especially for patients who are undergoing surgical procedures or require specialized care. Many hospitals have dedicated departments focusing on urology and incontinence management, providing a range of products tailored to patient needs. The adoption of urinary incontinence devices in hospitals is often driven by the latest medical standards and guidelines aimed at improving patient outcomes. Additionally, hospitals typically have partnerships with leading device manufacturers, ensuring that they have access to the latest products in the market. The increasing focus on patient-centered care and the need for effective urinary management solutions are further propelling the consumption of devices via hospital settings.

By Material Type

Silicone:

Silicone is a widely utilized material in the production of urinary incontinence devices due to its biocompatibility and flexibility. Many manufacturers prefer silicone for products such as catheters and absorbent items because it reduces the risk of allergic reactions and enhances comfort for the user. The durability and ease of cleaning of silicone devices also contribute to their popularity in both clinical and homecare settings. The growing demand for long-lasting and effective incontinence solutions is driving manufacturers to focus on silicone-based products, especially as consumer awareness regarding material safety continues to rise. This trend indicates a robust future for silicone-based urinary incontinence devices as they remain a preferred option for many patients.

Latex:

Latex is another material commonly used in urinary incontinence devices, particularly in the production of Foley catheters. The elasticity and strength of latex make it an effective choice for devices requiring flexibility and durability. However, the use of latex has declined due to increased awareness regarding latex allergies among patients. Manufacturers are now focusing on developing latex-free alternatives to cater to a broader audience while maintaining product effectiveness. Despite the challenges posed by latex allergies, its cost-effectiveness and functional benefits continue to make it a relevant material in specific segments of the urinary incontinence market.

Polyethylene:

Polyethylene is increasingly being employed in the production of various urinary incontinence products due to its lightweight properties and versatility. This material is particularly valuable in absorbent products, as it contributes to both comfort and effectiveness in urine retention. The advancements in polyethylene technology have led to the development of products that offer excellent moisture-wicking properties and minimize skin irritation. As consumers continue to seek reliable and comfortable incontinence solutions, the demand for polyethylene-based products is likely to rise. Manufacturers are expected to focus on enhancing the performance characteristics of polyethylene in their product offerings, resulting in further growth within this segment of the market.

Rubber:

Rubber is primarily utilized in the manufacturing of certain urinary devices, particularly in the production of inflatable cuffs for artificial urinary sphincters. The elasticity and strength of rubber make it an ideal choice for devices requiring a secure and adjustable fit. While its usage is more limited compared to silicone and polyethylene, rubber remains important in specific applications where flexibility and resilience are crucial. The continued focus on innovation in device design is likely to support the ongoing relevance of rubber in the urinary incontinence devices market. Manufacturers may explore advancements in synthetic rubber materials to enhance performance and user comfort, contributing to this segment's growth.

PVC:

Polyvinyl chloride (PVC) is a widely utilized material in the production of urinary incontinence devices, particularly in the manufacturing of catheters and absorbent products. PVC's versatility and cost-effectiveness make it a popular choice among manufacturers aiming to provide affordable yet effective solutions. The development of medical-grade PVC has further enhanced its safety and applicability in urinary incontinence products. However, the focus on biocompatibility and environmental concerns has led to increased research and development efforts aimed at producing more sustainable alternatives. Nevertheless, PVC remains integral to the urinary incontinence devices market, especially for manufacturers looking to balance affordability with performance.

By Region

The North American urinary incontinence devices market is poised for significant growth, driven by the increasing prevalence of urinary incontinence among the aging population and the rising awareness of available treatment options. The region is expected to dominate the market over the forecast period, accounting for approximately 40% of the global share by 2035. The United States, in particular, remains a key player due to its advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading manufacturers. The North American market is projected to grow at a CAGR of 4.6%, fueled by continuous innovation and product development in urinary incontinence devices.

In Europe, the urinary incontinence devices market is following closely behind, with Germany, France, and the UK being the largest contributors. The increasing focus on women's health, coupled with a growing aging population, is driving market demand for urinary incontinence devices in this region. The European market is expected to exhibit a steady growth rate, with key manufacturers investing in research and development to cater to the diverse needs of consumers. The cumulative market share of Europe is anticipated to reach around 30% by 2035, driven by both technological advancements and changing social attitudes towards urinary incontinence management.

Opportunities

The urinary incontinence devices market is rife with opportunities that can be capitalized on by manufacturers and healthcare providers alike. One key opportunity is the increasing demand for homecare products driven by the aging population. As more individuals prefer to manage their healthcare needs in the comfort of their homes, there is a growing market for user-friendly and discreet urinary incontinence devices designed for home use. Manufacturers who focus on creating high-quality, easily accessible products tailored to homecare settings can tap into this emerging trend effectively. Additionally, leveraging advancements in telehealth and remote patient monitoring can enhance the delivery of care, allowing for continuous support and education on managing urinary incontinence. Integrating technology and innovative solutions can provide a competitive advantage in this market.

Another significant opportunity lies in the rising awareness and acceptance of urinary incontinence products worldwide. As public perceptions shift towards recognizing incontinence as a common health issue, there is a need for educational campaigns that inform consumers about available solutions. Manufacturers and healthcare providers can collaborate to create awareness programs and marketing strategies that emphasize the benefits of various urinary incontinence devices. Furthermore, exploring emerging markets with growing healthcare infrastructures presents a promising avenue for expansion. Companies that invest in understanding regional needs and preferences can establish their presence in these markets, leading to increased sales and brand loyalty.

Threats

The urinary incontinence devices market faces several threats that may impede growth and development. One major threat is the potential for product recalls and safety concerns associated with urinary incontinence devices. As regulatory scrutiny continues to intensify, manufacturers must ensure compliance with stringent quality standards and maintain high safety protocols. Any incidents of product failure or adverse reactions can lead to significant financial losses and damage to brand reputation. Furthermore, increasing competition in the market has created a saturated landscape, with numerous players striving to gain market share. This heightened competition may drive down prices and impact profit margins, posing challenges for manufacturers aiming to maintain sustainable growth.

Another considerable concern is the potential for changing healthcare regulations, particularly in regions such as North America and Europe, where regulatory standards are continually evolving. Manufacturers must adapt to these changes to remain compliant and avoid disruptions in their operations. Additionally, the ongoing COVID-19 pandemic has led to shifts in healthcare priorities and resource allocation, which may impact the availability of urinary incontinence devices in certain markets. Economic fluctuations and changes in consumer spending behavior may also pose challenges for the growth of the urinary incontinence devices market, impacting overall sales performance.

Competitor Outlook

• Coloplast
• Medtronic
• Boston Scientific
• Hollister Incorporated
• ConvaTec
• Smith & Nephew
• Essity
• Kimberly-Clark Corporation
• Bard Medical
• Pfizer Inc.
• Amgen
• Stryker Corporation
• Uroplasty (a subsidiary of Cogentix Medical)
• Attends Healthcare Products
• Medline Industries

The competitive landscape of the urinary incontinence devices market is characterized by a diverse range of players, from established multinational corporations to emerging startups. Key companies are investing significantly in research and development to introduce innovative products that meet the evolving needs of consumers. The market is also witnessing a trend toward strategic partnerships and collaborations, as companies aim to enhance their product portfolios and expand their market reach. As the demand for urinary incontinence devices continues to rise, manufacturers are focusing on improving product quality, safety, and performance to maintain a competitive advantage in this growing market.

Coloplast, for instance, is a leading player in the urinary incontinence devices market, known for its innovative solutions and commitment to improving the quality of life for individuals with incontinence. The company has introduced various products, ranging from catheters to absorbent products, designed with user comfort in mind. With a strong focus on research and development, Coloplast continues to set industry standards and remains a formidable competitor in this space. Similarly, Medtronic is recognized for its advanced technologies and comprehensive product offerings, including electrical stimulation devices that enhance bladder control. Their commitment to improving patient outcomes and investing in continuous innovation positions them as a key player in the urinary incontinence devices market.

Boston Scientific is another significant competitor, offering a wide range of products for urinary incontinence management. The company has a strong presence in the artificial urinary sphincters segment and continues to develop cutting-edge technologies to address complex urinary incontinence cases. Their focus on leveraging data analytics and customer feedback to drive product development allows them to maintain a competitive edge. Other notable companies, such as Hollister Incorporated and ConvaTec, also play essential roles in the market, providing high-quality absorbent products and emphasizing consumer education and awareness. As competition intensifies, these companies are likely to engage in ongoing innovation and differentiation strategies to capture market share and meet diverse consumer needs.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amgen
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Essity
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ConvaTec
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Coloplast
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Pfizer Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Bard Medical
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Smith & Nephew
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Boston Scientific
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Medline Industries
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Stryker Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hollister Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Kimberly-Clark Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Attends Healthcare Products
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Uroplasty (a subsidiary of Cogentix Medical)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Urinary Incontinence Devices Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Homecare Settings
    • 6.1.4 Nursing Homes
  • 6.2 Urinary Incontinence Devices Market, By Product Type
    • 6.2.1 Electrical Stimulation Devices
    • 6.2.2 Foley Catheters
    • 6.2.3 Absorbent Products
    • 6.2.4 Artificial Urinary Sphincters
    • 6.2.5 Urethral Bulking Agents
  • 6.3 Urinary Incontinence Devices Market, By Material Type
    • 6.3.1 Silicone
    • 6.3.2 Latex
    • 6.3.3 Polyethylene
    • 6.3.4 Rubber
    • 6.3.5 PVC
  • 6.4 Urinary Incontinence Devices Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Medical Stores
    • 6.4.3 Retail Pharmacies
    • 6.4.4 Hospitals

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Urinary Incontinence Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Urinary Incontinence Devices market is categorized based on

By Product Type

• Electrical Stimulation Devices
• Foley Catheters
• Absorbent Products
• Artificial Urinary Sphincters
• Urethral Bulking Agents

By Application

• Hospitals
• Clinics
• Homecare Settings
• Nursing Homes

By Distribution Channel

• Online Stores
• Medical Stores
• Retail Pharmacies
• Hospitals

By Material Type

• Silicone
• Latex
• Polyethylene
• Rubber
• PVC

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Coloplast
• Medtronic
• Boston Scientific
• Hollister Incorporated
• ConvaTec
• Smith & Nephew
• Essity
• Kimberly-Clark Corporation
• Bard Medical
• Pfizer Inc.
• Amgen
• Stryker Corporation
• Uroplasty (a subsidiary of Cogentix Medical)
• Attends Healthcare Products
• Medline Industries